Lu XF - Search Results

1

Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer.

Dai N, Cao XJ, Li MX, Qing Y, Liao L, Lu XF, Zhang SH, Li Z, Yang YX, Wang D. Dai N, et al. Among authors: lu xf. PLoS One. 2013;8(3):e58001. doi: 10.1371/journal.pone.0058001. Epub 2013 Mar 5. PLoS One. 2013. PMID: 23472128 Free PMC article.

2

[meta-analysis of serum tumor markers in lung cancer].

LU X, YANG X, ZHANG Z, WANG D. LU X, et al. Zhongguo Fei Ai Za Zhi. 2010 Dec;13(12):1136-40. doi: 10.3779/j.issn.1009-3419.2010.12.11. Zhongguo Fei Ai Za Zhi. 2010. PMID: 21159250 Free PMC article. Chinese.

3

[Evaluation of serum cytokines in small cell lung cancer and its clinical significance].

Lu X, Yang X, Yang Y, Gu X, Liao L, Wang D. Lu X, et al. Zhongguo Fei Ai Za Zhi. 2012 Jan;15(1):11-6. doi: 10.3779/j.issn.1009-3419.2012.01.03. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22237118 Free PMC article. Chinese.

4

APE1 deficiency promotes cellular senescence and premature aging features.

Li M, Yang X, Lu X, Dai N, Zhang S, Cheng Y, Zhang L, Yang Y, Liu Y, Yang Z, Wang D, Wilson DM 3rd. Li M, et al. Nucleic Acids Res. 2018 Jun 20;46(11):5664-5677. doi: 10.1093/nar/gky326. Nucleic Acids Res. 2018. PMID: 29750271 Free PMC article.

5

The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer.

Yang X, Peng Y, Jiang X, Lu X, Duan W, Zhang S, Dai N, Shan J, Feng Y, Li X, Cheng Y, Yang Y, Baugh L, Tell G, Wang D, Li M. Yang X, et al. Cancer Med. 2018 Sep;7(9):4406-4419. doi: 10.1002/cam4.1717. Epub 2018 Aug 14. Cancer Med. 2018. PMID: 30109782 Free PMC article.

6

Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.

Liu J, Yang X, Lu X, Zhang L, Luo W, Cheng Y, Zhang L, Yang Y, Dai N, Xu Y, Guan Y, Xiao H, Li M, Wang D. Liu J, et al. Exp Cell Res. 2020 Sep 15;394(2):112134. doi: 10.1016/j.yexcr.2020.112134. Epub 2020 Jun 12. Exp Cell Res. 2020. PMID: 32540399

7

Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.

Pu Y, Lu X, Yang X, Yang Y, Wang D, Li M, Guan W, Xu M. Pu Y, et al. J Gastrointest Oncol. 2022 Feb;13(1):1-12. doi: 10.21037/jgo-21-686. J Gastrointest Oncol. 2022. PMID: 35284129 Free PMC article.

8

Next generation sequencing targeted detection of somatic mutations in patients with mucinous adenocarcinoma of the appendix.

Jian D, Lu X, Wang D, Li M, Yang Y, Chen Q, Qian C, Shao W, Dai N, Feng Y. Jian D, et al. Ann Diagn Pathol. 2022 Dec;61:152024. doi: 10.1016/j.anndiagpath.2022.152024. Epub 2022 Aug 8. Ann Diagn Pathol. 2022. PMID: 36122512

9

Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non-small cell lung cancer.

Hu Y, Li S, Xiao H, Xiong Y, Lu X, Yang X, Luo W, Luo J, Zhang S, Cheng Y, Zhang L, Dai X, Yang Y, Wang D, Li M. Hu Y, et al. Cancer Med. 2023 Jun;12(11):12234-12252. doi: 10.1002/cam4.5918. Epub 2023 Apr 16. Cancer Med. 2023. PMID: 37062076 Free PMC article.

10

Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair Analysis.

Yang L, Lu X, Luo J, Huang D, Dai X, Yang Y, Dai N, Xiong Y. Yang L, et al. Am J Clin Oncol. 2024 Mar 1;47(3):115-121. doi: 10.1097/COC.0000000000001066. Epub 2023 Nov 20. Am J Clin Oncol. 2024. PMID: 37981702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters